HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,599,280 | +19.7% | 120,400 | +13.1% | 0.00% | 0.0% |
| Q2 2023 | $3,841,455 | -28.0% | 106,500 | -23.8% | 0.00% | -50.0% |
| Q1 2023 | $5,338,962 | +15.1% | 139,800 | +71.5% | 0.00% | 0.0% |
| Q4 2022 | $4,637,350 | +21.9% | 81,500 | -15.3% | 0.00% | 0.0% |
| Q3 2022 | $3,804,000 | -54.9% | 96,200 | -49.8% | 0.00% | -50.0% |
| Q2 2022 | $8,439,000 | – | 191,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 238,400 | $4,670,000 | 0.05% |
| SIMPLEX TRADING, LLC | 124 | $14,000 | 0.00% |